<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The ADAM and ADAMTS families, also called adamalysins belong to an important group of extracellular matrix proteins </plain></SENT>
<SENT sid="1" pm="."><plain>The ADAMs family belong to both the transmembrane and secreted proteins, while ADAMTS family only contains secreted forms </plain></SENT>
<SENT sid="2" pm="."><plain>Adamalysins play an important role in the <z:mp ids='MP_0005384'>cell phenotype</z:mp> regulation via their activities in signaling pathways, cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> and migration </plain></SENT>
<SENT sid="3" pm="."><plain>The human proteome contains 21 ADAM, and 19 ADAMTS proteins, which are involved in extracellular matrix remodeling, shedding of various substrates such as: <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> ligands, growth factors, their receptors and diverse cytokines </plain></SENT>
<SENT sid="4" pm="."><plain>Recent studies provide evidence that adamalysins play a crucial role in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) etiopathogenesis </plain></SENT>
<SENT sid="5" pm="."><plain>It seems possible that adamalysins might be used as <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> prediction markers or potential pharmaceutical targets </plain></SENT>
<SENT sid="6" pm="."><plain>[BMB Reports 2013; 46(3): 139-150] </plain></SENT>
</text></document>